Abeona Therapeutics Announces Permanent J-Code for ZEVASKYN (prademagene zamikeracel)
CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO),…
11 New Living Soil THCA Strains Now Available at The Hemp Doctor
MOORESVILLE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor, a…
RAMSAY SANTE : availability of the Universal Registration Document 2025
PRESS RELEASE Paris, 29th October 2025 AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT 2025…
EmblemHealth and Prime Therapeutics Pioneer New Pharmacy Benefit Collaboration
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- EmblemHealth, one of the…
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings…
Canadian Red Cross opens appeal to help people impacted by Hurricane Melissa
OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has…
Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
MINNEAPOLIS and BRISBANE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies…
SonderCare Launches Impulse Essential 39 Residential Comfort Bed, Expanding Affordable Luxury Homecare Options in the United States
Introducing a new standard in entry-level homecare beds — SonderCare’s Impulse Essential…
Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the PARADIGM Trial)
MINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) --…
